This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
The determination of brain death is based on a comprehensive clinical assessment. A confirmatory test—at least, in adult patients in the United States—is not mandatory, but it typically is used as a safeguard or added when findings on clinical examination are unwontedly incomplete. In other countries, confirmatory tests are mandatory; in many, they are optional. These tests can be divided into those that test the brain's electrical function and those that test cerebral blood flow. A false-positive result (i.e., the test result suggests brain death, but clinically the patient does not meet the criteria) is not common but has been described for tests frequently used to determine brain death. A false-negative result (i.e., the test result suggests intact brain function, but clinically the patient meets the criteria) in one test may result in more confirmatory tests and no resolution when the test results diverge. Also, pathologic studies have shown that considerable areas of viable brain tissue may remain in patients who meet the clinical criteria of brain death, a fact that makes these tests less diagnostic. Confirmatory tests are residua from earlier days of refining comatose states. A comprehensive clinical examination, when performed by skilled examiners, should have perfect diagnostic accuracy.
Footnotes
-
Disclosure: Author disclosures are provided at the end of the article.
Received February 5, 2010. Accepted in final form April 5, 2010.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
- The case against confirmatory tests for determining brain death in adults
- Confirmatory tests for brain death determination: cum grano salis.
- Reply from the author
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen